Molecular Devices Introduces IonWorks System for High-Throughput Ion Channel Screening
Commenting on the launch of the IonWorks HT system, John Senaldi, Vice President and General Manager of IonWorks at Molecular Devices, noted, "Molecular Devices has a history of providing innovative solutions for drug discovery and life sciences research. With our new IonWorks HT system, we introduce an enabling alternative to the current gold-standard of electrophysiology screening. This new system overcomes many of the hurdles associated with traditional patch clamp methods by dramatically reducing the time and labor required to perform ion channel assays. The IonWorks HT system is designed to allow researchers to obtain reliable, reproducible results with considerably less effort." Senaldi further stated, "The IonWorks HT system adds to Molecular Devices' growing portfolio of tools that enable both high-content and high-throughput solutions for drug discovery research."
The IonWorks HT system performs whole-cell patch clamping on multiple cells in parallel and greatly increases throughput over existing high-information content methods. The system quickly loads the wells and achieves multiple seals at a time. During processing, the system measures whole-cell current from multiple cells simultaneously using the multi-channel (48) voltage clamp amplifier. The system aspirates from standard 96- and 384-well microplate formats and dispenses reagents in parallel with a 12-channel pipettor. With the IonWorks HT system, it is easy to set up and run experiments. Typical experiments measure an entire plate in about 30 minutes -- translating into overall throughput of up to 3,000 patches per day.
Other news from the department research and development
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.